EPISODE · Mar 27, 2025 · 44 MIN
EASL Studio Podcast: Rare Liver Malignancies: Small Numbers, Big Questions
from EASL Podcasts
Rare liver tumors like combined HCC/CCA, fibrolamellar HCC, and haemangioendothelioma pose significant diagnostic and therapeutic challenges. In this episode, we explore the latest insights, controversies, and clinical approaches outlined in the new EASL position paper. Join us to uncover how these advancements can address key hurdles in managing these rare malignancies.Read the position paper: Rare primary liver cancers: An EASL position paperModerator: Thomas BergFaculty: Ruben de Kleine and Henning WegeRelated episodesS6E4: World Cholangiocarcinoma Day: Highlighting guidelines and exploring the horizon beyondS5E13: Basics in decision-making for liver cancer treatmentS4 Special Edition 1: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillanceAll EASL Studio Podcasts are available on EASL Campus.Click here to see all EASL Video Podcasts on Apple Podcasts.
Embed this episode
What this episode covers
Rare liver tumors like combined HCC/CCA, fibrolamellar HCC, and haemangioendothelioma pose significant diagnostic and therapeutic challenges. In this episode, we explore the latest insights, controversies, and clinical approaches outlined in the new EASL position paper. Join us to uncover how these advancements can address key hurdles in managing these rare malignancies. Read the position paper: Rare primary liver cancers: An EASL position paper Moderator: Thomas Berg Faculty: Ruben de Kleine...
NOW PLAYING
EASL Studio Podcast: Rare Liver Malignancies: Small Numbers, Big Questions
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.